Breaking News

You are here » Indian-Commodity  :  Commodities  :  Cardamom  :  Cardamom futures trade lower on MCX

20-Sep2016

Cardamom futures trade lower on MCX

Cardamom futures traded lower on MCX as investors cut down their positions amid slide in physical demand for cardamom in the domestic spot market. Further, sufficient supplies amid higher physical arrivals from the major cardamom producing regions too fuelled the downtrend.

The contract for October delivery was trading at Rs 1180.00, down by 0.20% or Rs 2.40 from its previous closing of Rs 1182.40.The open interest of the contract stood at 994.00 lots.

The contract for November delivery was trading at Rs 1204.60, down by 0.29% or Rs 3.50 from its previous closing of Rs 1208.10. The open interest of the contract stood at 463.00 lots on MCX.


Related News

View all news

Cardamom futures trade tad higher on firm demand

Cardamom futures traded marginally higher on MCX, due to short covering as demand firmed up in physical markets amid shortage in arrivals from growing regions. The contract for March delivery was trading......

Cardamom futures tumble on profit taking

Cardamom futures trade higher on MCX, due to profit taking by participants after the spice rose with the decline in arrivals.The contract for April delivery was trading at Rs 1500.00, down by 1.32% or......

Cardamom futures trade higher on robust demand

Cardamom futures traded higher on MCX, with enlargement of portfolios tracking robust demand from physical domestic and export markets.The contract for February delivery was trading at Rs 1560.00, up by......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......